WHY DO METABOLIC RISK FACTORS CLUSTER WITH HYPERTENSION?
为什么代谢风险因素与高血压密切相关?
基本信息
- 批准号:6603737
- 负责人:
- 金额:$ 22.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-20 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the application) Insulin resistance has been
frequently observed in patients with essential hypertension, although the
mechanisms responsible for the hypertension "metabolic syndrome" and clustering
of cardiovascular risk factors remain poorly understood. Evidence from both
family studies and experimental animals indicates that genetic risk factors may
play a significant role in the clustering of cardiovascular risk factors.
The spontaneously hypertensive rat (SHR), a widely studied experimental animal
model of human essential hypertension, also demonstrates increased plasma
insulin levels and insulin resistance when compared with other strains with low
blood pressure. The PI and her collaborators have derived a novel SHR congenic
strain that provides an opportunity to investigate the clustering of
hypertension and insulin resistance. By transferring a piece of chromosome 4
from the normotensive Brown Norway rat onto the genetic background of the SHR
rat, the applicant has bracketed a specific chromosomal segment approximately
37 cM in size, that improves both blood pressure and insulin resistance in the
SHR. This segment also contains the Cd36 gene, which encodes a fatty acid
transporter that was previously thought to be a candidate in the pathogenesis
of insulin resistance and blood pressure. The PI proposes to use meiotic
mapping in an interval specific segregating population to narrowly map the
blood pressure locus on chromosome 4, derive a congenic subline that carries
the relevant segment of chromosome 4 and test the potential role of Cd36 in
blood pressure control and insulin resistance in transgenic SHR by
overexpressing this gene.
描述:(改编自应用程序)胰岛素抵抗已被
在原发性高血压患者中经常观察到,
机制负责高血压“代谢综合征”和集群
心血管疾病的危险因素仍然知之甚少。双方的证据
家庭研究和实验动物表明,遗传风险因素可能
在心血管危险因素聚集中起重要作用。
自发性高血压大鼠(SHR)是一种被广泛研究的实验动物
人原发性高血压模型,也表明血浆中
胰岛素水平和胰岛素抵抗与其他菌株相比,
血压. PI和她的合作者已经推导出一种新的SHR同源基因
菌株,提供了一个机会,调查集群的
高血压和胰岛素抵抗。通过转移一段4号染色体
从血压正常的布朗挪威大鼠到SHR的遗传背景
在大鼠中,申请人将特定的染色体片段括起来,
37厘米的大小,这改善了血压和胰岛素抵抗,
SHR。该片段还包含Cd36基因,其编码脂肪酸
转运蛋白,以前被认为是一个候选人在发病机制
胰岛素抵抗和血压的关系。PI建议使用减数分裂
在区间特异性分离群体中作图,
4号染色体上的血压位点,衍生出一个携带
4号染色体的相关片段,并测试Cd36在
转基因SHR的血压控制和胰岛素抵抗
过度表达这个基因。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
- DOI:10.1161/hypertensionaha.109.138750
- 发表时间:2009-12
- 期刊:
- 影响因子:0
- 作者:Yamamoto K;Ohishi M;Ho C;Kurtz TW;Rakugi H
- 通讯作者:Rakugi H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THEODORE W KURTZ其他文献
THEODORE W KURTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THEODORE W KURTZ', 18)}}的其他基金
Genetics of risk factor clustering in hypertension
高血压危险因素聚类的遗传学
- 批准号:
6735483 - 财政年份:2003
- 资助金额:
$ 22.13万 - 项目类别:
WHY DO METABOLIC RISK FACTORS CLUSTER WITH HYPERTENSION?
为什么代谢风险因素与高血压密切相关?
- 批准号:
6527239 - 财政年份:2000
- 资助金额:
$ 22.13万 - 项目类别:
相似海外基金
Pioneering reproductive biotechnology innovations for equine breeding
开创马匹育种生殖生物技术创新
- 批准号:
LP230100156 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Linkage Projects
Industrial Biotechnology Innovation Cluster
产业生物技术创新集群
- 批准号:
EP/Y024168/1 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Research Grant
Environmental Biotechnology Innovation Centre
环境生物技术创新中心
- 批准号:
BB/Y008332/1 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Research Grant
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
- 批准号:
2330663 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Standard Grant
Conference: Translating Molecular Science Innovations into Biotechnology Solutions
会议:将分子科学创新转化为生物技术解决方案
- 批准号:
2419731 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Standard Grant
Shear Innovation: Valorising wool waste using biotechnology to enhance horticultural peat-free growing media
剪切创新:利用生物技术提高羊毛废料的价值,以增强园艺无泥炭生长介质
- 批准号:
10106787 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Launchpad
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
- 批准号:
2421022 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Standard Grant
NSF Convergence Accelerator Track M: Biofilm-based Corrosion Control using 3D Printed Biotechnology
NSF 融合加速器轨道 M:使用 3D 打印生物技术进行基于生物膜的腐蚀控制
- 批准号:
2344389 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Standard Grant
Engineering Biology Hub for environmental processing and recovery of metals; from contaminated land to industrial biotechnology in a circular economy
用于环境处理和金属回收的工程生物中心;
- 批准号:
BB/Y008456/1 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Research Grant
Development of magnetic force biotechnology to facilitate neural regeneration
开发磁力生物技术促进神经再生
- 批准号:
EP/X014126/1 - 财政年份:2023
- 资助金额:
$ 22.13万 - 项目类别:
Research Grant